Licensing Agreement
MEI Pharma and Kyowa Hakko Kirin Announce License Agreement to Develop and Commercialize ME-401 in Japan
MEI Pharma, Inc.
PR-M11-18-NI-026Nov 08, 2018
Orphan Drug Designation
Helsinn Group and MEI Pharma Announce that Pracinostat has Received Orphan Drug Designation from the European Medicines Agency for the Treatment of Acute Myeloid Leukemia (AML)
MEI Pharma, Inc.
PR-M01-18-NI-045Jan 16, 2018